News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
633,497 Results
Type
Article (48591)
Company Profile (220)
Press Release (584686)
Multimedia
Podcasts (126)
Webinars (19)
Section
Business (177711)
Career Advice (2603)
Deals (32719)
Drug Delivery (124)
Drug Development (79312)
Employer Resources (164)
FDA (16450)
Job Trends (13707)
News (314878)
Policy (32645)
Tag
Academia (2432)
Academic (1)
Accelerated approval (12)
Adcomms (32)
Allergies (96)
Alliances (45123)
ALS (115)
Alzheimer's disease (1530)
Antibody-drug conjugate (ADC) (179)
Approvals (16401)
Artificial intelligence (338)
Autoimmune disease (35)
Automation (15)
Bankruptcy (330)
Best Places to Work (10205)
BIOSECURE Act (22)
Biosimilars (135)
Biotechnology (113)
Bladder cancer (96)
Brain cancer (37)
Breast cancer (362)
Cancer (2875)
Cardiovascular disease (230)
Career advice (2174)
Career pathing (34)
CAR-T (184)
CDC (41)
Cell therapy (517)
Cervical cancer (22)
Clinical research (65389)
Collaboration (993)
Company closure (3)
Compensation (704)
Complete response letters (33)
COVID-19 (2707)
CRISPR (59)
C-suite (326)
Cystic fibrosis (111)
Data (2927)
Decentralized trials (2)
Denatured (32)
Depression (74)
Diabetes (348)
Diagnostics (5719)
Digital health (22)
Diversity (9)
Diversity, equity & inclusion (43)
Drug discovery (143)
Drug pricing (149)
Drug shortages (35)
Duchenne muscular dystrophy (132)
Earnings (71428)
Editorial (48)
Employer branding (20)
Employer resources (148)
Events (96745)
Executive appointments (834)
FDA (18127)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (4)
Frontotemporal dementia (8)
Funding (869)
Gene editing (129)
Generative AI (28)
Gene therapy (401)
GLP-1 (905)
Government (4170)
Grass and pollen (6)
Guidances (176)
Healthcare (16079)
HIV (43)
Huntington's disease (32)
IgA nephropathy (44)
Immunology and inflammation (178)
Immuno-oncology (11)
Indications (39)
Infectious disease (2892)
Inflammatory bowel disease (153)
Inflation Reduction Act (11)
Influenza (64)
Intellectual property (118)
Interviews (476)
IPO (15461)
IRA (53)
Job creations (3873)
Job search strategy (1818)
Kidney cancer (14)
Labor market (49)
Layoffs (562)
Leadership (26)
Legal (7913)
Liver cancer (82)
Longevity (12)
Lung cancer (404)
Lymphoma (209)
Machine learning (11)
Management (58)
Manufacturing (412)
MASH (96)
Medical device (11712)
Medtech (11716)
Mergers & acquisitions (17976)
Metabolic disorders (928)
Multiple sclerosis (103)
NASH (23)
Neurodegenerative disease (132)
Neuropsychiatric disorders (41)
Neuroscience (2250)
NextGen: Class of 2025 (5542)
Non-profit (3451)
Now hiring (37)
Obesity (491)
Opinion (276)
Ovarian cancer (93)
Pain (114)
Pancreatic cancer (118)
Parkinson's disease (194)
Partnered (19)
Patents (304)
Patient recruitment (161)
Peanut (50)
People (52953)
Pharmaceutical (89)
Pharmacy benefit managers (25)
Phase I (20158)
Phase II (28418)
Phase III (22116)
Pipeline (1666)
Policy (241)
Postmarket research (2611)
Preclinical (8234)
Press Release (50)
Prostate cancer (146)
Psychedelics (45)
Radiopharmaceuticals (253)
Rare diseases (503)
Real estate (5427)
Recruiting (66)
Regulatory (23212)
Reports (38)
Research institute (2238)
Resumes & cover letters (428)
Rett syndrome (9)
RNA editing (8)
RSV (54)
Schizophrenia (98)
Series A (158)
Series B (105)
Service/supplier (14)
Sickle cell disease (65)
Special edition (22)
Spinal muscular atrophy (156)
Sponsored (36)
Startups (3354)
State (2)
Stomach cancer (17)
Supply chain (81)
Tariffs (65)
The Weekly (92)
Vaccines (883)
Venture capital (57)
Weight loss (331)
Women's health (43)
Worklife (20)
Date
Today (86)
Last 7 days (366)
Last 30 days (1826)
Last 365 days (30729)
2025 (16836)
2024 (33913)
2023 (37973)
2022 (48622)
2021 (52398)
2020 (49774)
2019 (40611)
2018 (31005)
2017 (31309)
2016 (30111)
2015 (33776)
2014 (27447)
2013 (23079)
2012 (24736)
2011 (25346)
2010 (23294)
Location
Africa (791)
Alabama (54)
Alaska (7)
Arizona (201)
Arkansas (12)
Asia (39499)
Australia (6528)
California (7155)
Canada (2105)
China (659)
Colorado (310)
Connecticut (330)
Delaware (197)
Europe (89203)
Florida (1100)
Georgia (224)
Hawaii (2)
Idaho (45)
Illinois (592)
India (29)
Indiana (316)
Iowa (17)
Japan (229)
Kansas (95)
Kentucky (27)
Louisiana (13)
Maine (67)
Maryland (1011)
Massachusetts (5445)
Michigan (211)
Minnesota (413)
Mississippi (2)
Missouri (77)
Montana (18)
Nebraska (22)
Nevada (75)
New Hampshire (57)
New Jersey (2037)
New Mexico (26)
New York (1979)
North Carolina (1082)
North Dakota (7)
Northern California (3175)
Ohio (203)
Oklahoma (11)
Oregon (32)
Pennsylvania (1501)
Puerto Rico (15)
Rhode Island (28)
South America (1168)
South Carolina (33)
South Dakota (1)
Southern California (2688)
Tennessee (115)
Texas (1036)
United States (26443)
Utah (188)
Virginia (187)
Washington D.C. (74)
Washington State (609)
West Virginia (4)
Wisconsin (71)
633,497 Results for "zealand pharma a s".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Obesity
Zealand’s GLP-1/GLP-2 Drug Elicits Over 11% Weight-Loss—With the Potential for More
Analysts at William Blair say dapiglutide’s 11.6% weight reduction at 28 weeks could still be better, given that Zealand’s study predominantly included men and enrolled patients with lower BMI at baseline.
June 20, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Zealand Pharma launches long-term incentive programs for Zealand Pharma’s Board of Directors, Corporate Management and employees for 2025
April 21, 2025
·
7 min read
Press Releases
Zealand Pharma announces closing of collaboration and license agreement with Roche
May 9, 2025
·
1 min read
Press Releases
Zealand Pharma Announces Financial Results for the First Three Months of 2025
May 8, 2025
·
11 min read
Press Releases
Zealand Pharma to participate in upcoming healthcare investor conferences in May and June 2025
May 12, 2025
·
2 min read
Press Releases
Zealand Pharma submits Marketing Authorization Application to the European Medicines Agency for glepaglutide in short bowel syndrome
June 2, 2025
·
7 min read
Press Releases
Resolutions from Zealand Pharma’s Annual General Meeting 2025
March 28, 2025
·
5 min read
Press Releases
Zealand Pharma announces positive topline results from 28-week Phase 1b trial with GLP-1/GLP-2 receptor dual agonist dapiglutide
June 18, 2025
·
8 min read
Press Releases
Zealand Pharma continues to strengthen strategic leadership of innovation in obesity and related conditions with appointment of Steven Johnson as Chief Development Officer
May 19, 2025
·
6 min read
Press Releases
Zealand Pharma appoints Utpal Singh as Chief Scientific Officer to drive next-generation peptide therapeutics discovery
April 23, 2025
·
6 min read
1 of 63,350
Next
